These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13370600)

  • 41. Clinical experience with U-2043 (orinase).
    CLARKE WT
    Can Med Assoc J; 1956 Jun; 74(12):998. PubMed ID: 13329958
    [No Abstract]   [Full Text] [Related]  

  • 42. [New hypoglycemic substances].
    ACHELIS JD; HAACK E; HARDEBECK K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):163-5. PubMed ID: 13334598
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of BZ-55 and D-860 on blood sugar and blood phosphorus, sodium and potassium in dogs].
    MOHNIKE G; BIBERGEIL H
    Dtsch Med Wochenschr; 1956 Jun; 81(22):900-2. PubMed ID: 13344023
    [No Abstract]   [Full Text] [Related]  

  • 44. Hypoglycemic effects of 1-butyl-3-p-toluene sulfonylurea given orally in human diabetic subjects; a preliminary report.
    MILLER M; CRAIG JW
    Metabolism; 1956 Mar; 5(2):162-4. PubMed ID: 13296878
    [No Abstract]   [Full Text] [Related]  

  • 45. Ineffectiveness of sulfonylureas in alloxan diabetic rats.
    MIRSKY IA; PERISUTTI G; JINKS R
    Proc Soc Exp Biol Med; 1956 Mar; 91(3):475-7. PubMed ID: 13322970
    [No Abstract]   [Full Text] [Related]  

  • 46. Intrapancreatic infusions of the sulfonylureas.
    COLWELL AR; COLWELL JA
    Diabetes; 1957; 6(1):60; discussion, 62. PubMed ID: 13397425
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of nadisan (BZ 55) on blood sugar in dogs with resected pancreas].
    BECKER WH; BUDDECKE E; MULLER H
    Klin Wochenschr; 1956 Sep; 34(33-34):920-1. PubMed ID: 13368430
    [No Abstract]   [Full Text] [Related]  

  • 48. [Usefulness of blood sugar decreasing sulfonamides for insulin shock treatment in psychiatry].
    BAYREUTHER H; SPECHT N
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1956; 195(2):132-9. PubMed ID: 13382306
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical experience with carbutamide and tolbutamide.
    COHN C; HEINEMAN A; LEVINE R; WEINSTEIN M
    Metabolism; 1956 Nov; 5(6 Part 2):972-7. PubMed ID: 13378067
    [No Abstract]   [Full Text] [Related]  

  • 50. [Blood protein changes after oral administration of a blood-sugar lowering sulfonamide (invenol)].
    MUTING D
    Klin Wochenschr; 1956 Sep; 34(33-34):919. PubMed ID: 13368428
    [No Abstract]   [Full Text] [Related]  

  • 51. CARBUTAMIDE and tolbutamide in diabetes.
    S Afr Med J; 1956 Dec; 30(51):1221-2. PubMed ID: 13391101
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of the exocrine secretion of the pancreas on blood sugar regulation. II. Research on the hypoglycemic sulfonamides in pancreatectomized dogs].
    BECKER WH
    Acta Neuroveg (Wien); 1958; 19(1-2):119-37. PubMed ID: 13605689
    [No Abstract]   [Full Text] [Related]  

  • 53. Metabolic effects of arylsulfonylurea compounds in normal subjects and in diabetic patients.
    CONN JW; FAJANS SS; HENNES AR; WAJCHENBERG BL
    Diabetes; 1957; 6(1):41-3; discussion, 43-5. PubMed ID: 13397421
    [No Abstract]   [Full Text] [Related]  

  • 54. Insulin-sparing sulfonamides.
    KINSELL LW; BROWN FR; FRISKEY GD; MICHAELS GD
    Science; 1956 Apr; 123(3197):585. PubMed ID: 13311506
    [No Abstract]   [Full Text] [Related]  

  • 55. Hypoglycemic sulfonylureas in various types of experimental diabetes.
    BUSE JF; GORDON MF; LUKENS FD
    Diabetes; 1957; 6(1):7-12; discussion, 19-20. PubMed ID: 13397410
    [No Abstract]   [Full Text] [Related]  

  • 56. Sulfonylureas and diabetes mellitus. II. Preliminary studies of the mechanism of action.
    COX RW; HENLEY ED; WILLIAMS RH
    Diabetes; 1956; 5(5):366-77. PubMed ID: 13365476
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experimental study of the effect of BZ 55 on normal or alloxan-treated rats. II. Effect on blood sugar].
    BELLENS R; CHRISTOPHE J; GEPTS W
    Ann Endocrinol (Paris); 1956 Jul; 17(2):291-8. PubMed ID: 13355058
    [No Abstract]   [Full Text] [Related]  

  • 58. Action of butyltolylsulfonylurea on liver glycogenolysis.
    TYBERGHEIN JM; HALSEY YD; WILLIAMS RH
    Proc Soc Exp Biol Med; 1956 Jun; 92(2):322-4. PubMed ID: 13350335
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of diabetic patients; observations on the use of carbutamide and tolbutamide.
    BROWN FR; FRISKEY RW; GRINDLE L; KINSELL LW; SPLITTER S
    Calif Med; 1956 Nov; 85(5):285-8. PubMed ID: 13364673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use & mechanism of action of sulfonamide derivatives decreasing the blood sugar in insulin shock therapy in psychiatry].
    BAYREUTHER H
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1957; 195(5):435-45. PubMed ID: 13435855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.